04:08 PM EDT, 06/13/2024 (MT Newswires) -- Leonard S Schleifer, Director, Board Co-Chair, President & CEO, on June 11, 2024, sold 25,213 shares in Regeneron Pharmaceuticals ( REGN ) for $25,610,229. Following the Form 4 filing with the SEC, Schleifer has control over a total of 630,361 shares of the company, with 466,877 shares held directly and 163,484 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/872589/000110465924071247/xslF345X03/tm2417175-1_4seq1.xml